Detalhe da pesquisa
1.
Fixed-duration ibrutinib plus venetoclax for first-line treatment of CLL: primary analysis of the CAPTIVATE FD cohort.
Blood
; 139(22): 3278-3289, 2022 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35196370
2.
Frontline Therapy in Chronic Lymphocytic Leukemia.
Acta Haematol
; 147(1): 47-59, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-37899041
3.
Fixed-duration ibrutinib-venetoclax versus chlorambucil-obinutuzumab in previously untreated chronic lymphocytic leukaemia (GLOW): 4-year follow-up from a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 24(12): 1423-1433, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37944541
4.
Sequence matters: Total body irradiation (TBI)-based myeloablative conditioning with post-transplant cyclophosphamide may reduce the early nonrelapse mortality compared with pretransplant cyclophosphamide plus TBI.
Eur J Haematol
; 111(1): 146-153, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37058419
5.
Many People With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Benefit From Ibrutinib Treatment Up To 8 Years: A Plain Language Summary.
Future Oncol
; 2023 01 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36617990
6.
Long-term efficacy of first-line ibrutinib treatment for chronic lymphocytic leukaemia in patients with TP53 aberrations: a pooled analysis from four clinical trials.
Br J Haematol
; 196(4): 947-953, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34865212
7.
First-line treatment of chronic lymphocytic leukemia with ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab: final analysis of the randomized, phase III iLLUMINATE trial.
Haematologica
; 107(9): 2108-2120, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35021599
8.
The road to chemotherapy-free treatment in chronic lymphocytic leukaemia.
Curr Opin Oncol
; 33(6): 670-680, 2021 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34474439
9.
Long-term follow-up of the RESONATE phase 3 trial of ibrutinib vs ofatumumab.
Blood
; 133(19): 2031-2042, 2019 05 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30842083
10.
Pretreatment with ibrutinib reduces cytokine secretion and limits the risk of obinutuzumab-induced infusion-related reactions in patients with CLL: analysis from the iLLUMINATE study.
Ann Hematol
; 100(7): 1733-1742, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34018029
11.
High-risk chronic lymphocytic leukemia in the era of pathway inhibitors: integrating molecular and cellular therapies.
Blood
; 132(9): 892-902, 2018 08 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-29997221
12.
When an HLA identical donor is not available in adults with hematological neoplasms: single-center comparison of single-unit cord blood transplantation and haploidentical-related PBSC transplantation with PTCy using a standardized conditioning platform (thiotepa-busulfan-fludarabine).
Ann Hematol
; 99(1): 157-165, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31844931
13.
Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trial.
Lancet Oncol
; 20(1): 43-56, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30522969
14.
Impact of ibrutinib dose adherence on therapeutic efficacy in patients with previously treated CLL/SLL.
Blood
; 129(19): 2612-2615, 2017 05 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28373262
15.
Final analysis from RESONATE: Up to six years of follow-up on ibrutinib in patients with previously treated chronic lymphocytic leukemia or small lymphocytic lymphoma.
Am J Hematol
; 94(12): 1353-1363, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31512258
16.
Optimising outcomes for patients with chronic lymphocytic leukaemia on ibrutinib therapy: European recommendations for clinical practice.
Br J Haematol
; 180(5): 666-679, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29318593
17.
Autoimmune cytopenia and CLL ride together.
Blood
; 137(25): 3464-3465, 2021 06 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34165542
18.
MRD in CLL: some answers, many questions.
Blood
; 138(26): 2746-2747, 2021 12 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34967869
19.
Sustained efficacy and detailed clinical follow-up of first-line ibrutinib treatment in older patients with chronic lymphocytic leukemia: extended phase 3 results from RESONATE-2.
Haematologica
; 103(9): 1502-1510, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29880603
20.
Rituximab plus bendamustine or chlorambucil for chronic lymphocytic leukemia: primary analysis of the randomized, open-label MABLE study.
Haematologica
; 103(4): 698-706, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29419437